We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
-0.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.9B
AUM Growth
+$100M
Cap. Flow
+$395M
Cap. Flow %
2.66%
Top 10 Hldgs %
17.57%
Holding
1,180
New
163
Increased
345
Reduced
462
Closed
161

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$162M
2
CPT icon
Camden Property Trust
CPT
+$93.1M
3
PSX icon
Phillips 66
PSX
+$76.3M
4
KR icon
Kroger
KR
+$55.2M
5
INTC icon
Intel
INTC
+$54.6M

Top Sells

Rank Stock Value
1
COF icon
Capital One
COF
+$80M
2
CABO icon
Cable One
CABO
+$75.5M
3
HPQ icon
HP
HPQ
+$61M
4
INTU icon
Intuit
INTU
+$57.6M
5
PARA
Paramount Global Class B
PARA
+$57.6M

Sector Composition

Rank Sector Weight
1 Technology 21.43%
2 Healthcare 13.24%
3 Consumer Discretionary 13.18%
4 Financials 12.14%
5 Industrials 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXGN icon
1001
Axogen
AXGN
$2.19B
$160K ﹤0.01%
+10,114
New +$182K
SLDB icon
1002
Solid Biosciences
SLDB
$767M
$153K ﹤0.01%
4,278
-6,353
-60% -$270K
PCTI
1003
DELISTED
PCTEL, Inc. Common Stock
PCTI
$148K ﹤0.01%
23,837
+565
+2% +$3.69K
SPRB
1004
Spruce Biosciences
SPRB
$115M
$146K ﹤0.01%
+325
New +$204K
CMPI
1005
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$145K ﹤0.01%
+36,511
New +$188K
DNTH icon
1006
Dianthus Therapeutics
DNTH
$5.62B
$144K ﹤0.01%
1,232
-8,299
-87% -$967K
DTIL icon
1007
Precision BioSciences
DTIL
$183M
$143K ﹤0.01%
414
ALTG icon
1008
Alta Equipment Group
ALTG
$204M
$139K ﹤0.01%
10,143
XXII
1009
22nd Century Group
XXII
$1.38M
0
ASUR icon
1010
Asure Software
ASUR
$225M
$127K ﹤0.01%
+14,057
New +$124K
MNTX
1011
DELISTED
Manitex International, Inc.
MNTX
$126K ﹤0.01%
17,500
+3,200
+22% +$23.8K
CRD.B icon
1012
Crawford & Co Class B
CRD.B
$504M
$119K ﹤0.01%
13,330
KINS icon
1013
Kingstone Companies
KINS
$288M
$119K ﹤0.01%
+17,875
New +$130K
CRBP icon
1014
Corbus Pharmaceuticals
CRBP
$164M
$117K ﹤0.01%
+3,816
New +$151K
PHAS
1015
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$97K ﹤0.01%
+31,324
New +$105K
PRTK
1016
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$79K ﹤0.01%
+16,185
New +$89.2K
FTK icon
1017
Flotek Industries
FTK
$814M
$69K ﹤0.01%
+9,072
New +$81.8K
ARAV
1018
DELISTED
Aravive, Inc. Common Stock
ARAV
$45K ﹤0.01%
+12,127
New +$51.8K
AFI
1019
DELISTED
Armstrong Flooring, Inc.
AFI
$41K ﹤0.01%
+13,113
New +$53.9K
AA icon
1020
Alcoa
AA
$11.7B
-37,212
Closed -$1.37M
ACLS icon
1021
Axcelis
ACLS
$3.52B
-11,299
Closed -$457K
ADPT icon
1022
Adaptive Biotechnologies
ADPT
$3.62B
-14,773
Closed -$604K
ADSK icon
1023
Autodesk
ADSK
$49.9B
-11,720
Closed -$3.42M
AEO icon
1024
American Eagle Outfitters
AEO
$3.03B
-13,201
Closed -$495K
AES icon
1025
AES
AES
$10.6B
-28,775
Closed -$750K

Similar funds

Jacobs Levy Equity Management's Q3 2021 Portfolio in Review

As of Q3 2021, Jacobs Levy Equity Management held 1,180 positions worth $14.9B, up 0.68% from $14.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Jacobs Levy Equity Management's Q3 2021 filing shows 163 new, 345 increased, 462 reduced and 161 closed positions. Its largest new stake was Camden Property Trust: 634,988 shares worth $93.6M. The largest sale was Capital One, an estimated $80M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q3 2021 buy was Camden Property Trust: 634,988 shares worth $93.6M.
  • Jacobs Levy Equity Management added most to Intuitive Surgical in Q3 2021, an estimated $162M increase.
  • Jacobs Levy Equity Management's biggest Q3 2021 reduction was Capital One, cutting an estimated $80M.
  • Jacobs Levy Equity Management fully exited Paramount Global Class B in Q3 2021, selling an estimated $57.6M.
  • Jacobs Levy Equity Management's ten largest holdings make up 18% of its $14.9B portfolio in Q3 2021.
  • Jacobs Levy Equity Management opened 163 new positions and closed 161 in Q3 2021.
  • Jacobs Levy Equity Management's portfolio value rose 0.68% quarter-over-quarter to $14.9B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2021, filed 15 Nov 2021.